Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
62
DTM Quote, Financials, Valuation and Earnings
Last price:
$101.17
Seasonality move
:
2.16%
Day range:
$97.29 - $101.45
52-week range:
$51.17 - $109.85
Dividend yield:
2.91%
P/E ratio:
24.55x
P/S ratio:
10.12x
P/B ratio:
2.32x
Volume:
5.1M
Avg. volume:
1.1M
1-year change:
88.65%
Market cap:
$9.8B
Revenue:
$922M
EPS (TTM):
$4.11
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $504M | $754M | $840M | $920M | $922M | |
| Revenue Growth (YoY) | 3.92% | 49.6% | 11.41% | 9.52% | 0.22% | |
| Cost of Revenues | $93M | $152M | $166M | $170M | $182M | |
| Gross Profit | $411M | $602M | $674M | $750M | $740M | |
| Gross Profit Margin | 81.55% | 79.84% | 80.24% | 81.52% | 80.26% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $97M | $132M | $111M | $174M | $182M | |
| Operating Expenses | $149M | $190M | $255M | $295M | $273M | |
| Operating Income | $262M | $412M | $419M | $455M | $467M | |
| Net Interest Expenses | $67M | $104M | $108M | $147M | $149M | |
| EBT. Incl. Unusual Items | $292M | $440M | $422M | $482M | $500M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $72M | $116M | $104M | $100M | $104M | |
| Net Income to Company | $220M | $324M | $318M | $382M | $396M | |
| Minority Interest in Earnings | -$16M | -$12M | -$11M | -$12M | -$12M | |
| Net Income to Common Excl Extra Items | $204M | $312M | $307M | $370M | $384M | |
| Basic EPS (Cont. Ops) | $2.11 | $3.22 | $3.17 | $3.83 | $3.97 | |
| Diluted EPS (Cont. Ops) | $2.11 | $3.22 | $3.16 | $3.81 | $3.94 | |
| Weighted Average Basic Share | $96.9M | $96.9M | $96.7M | $96.7M | $96.9M | |
| Weighted Average Diluted Share | $96.9M | $96.9M | $96.9M | $97.2M | $97.5M | |
| EBITDA | $477M | $722M | $718M | $808M | $850M | |
| EBIT | $367M | $553M | $534M | $619M | $650M | |
| Revenue (Reported) | $504M | $754M | $840M | $920M | $922M | |
| Operating Income (Reported) | $262M | $412M | $419M | $455M | $467M | |
| Operating Income (Adjusted) | $367M | $553M | $534M | $619M | $650M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $203M | $212M | $235M | $234M | $248M | |
| Revenue Growth (YoY) | -- | 4.43% | 10.85% | -0.43% | 5.98% | |
| Cost of Revenues | $38M | $42M | $42M | $46M | $53M | |
| Gross Profit | $165M | $170M | $193M | $188M | $195M | |
| Gross Profit Margin | 81.28% | 80.19% | 82.13% | 80.34% | 78.63% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $49M | $31M | $36M | $42M | $40M | |
| Operating Expenses | $45M | $64M | $72M | $65M | $73M | |
| Operating Income | $120M | $106M | $121M | $123M | $122M | |
| Net Interest Expenses | $25M | $31M | $34M | $38M | $41M | |
| EBT. Incl. Unusual Items | $144M | $106M | $123M | $127M | $121M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $39M | $29M | $7M | $33M | $30M | |
| Net Income to Company | $105M | $77M | $116M | $94M | $91M | |
| Minority Interest in Earnings | -$4M | -$3M | -$3M | -$3M | -$3M | |
| Net Income to Common Excl Extra Items | $101M | $74M | $113M | $91M | $88M | |
| Basic EPS (Cont. Ops) | $1.04 | $0.77 | $1.17 | $0.94 | $0.91 | |
| Diluted EPS (Cont. Ops) | $1.04 | $0.77 | $1.16 | $0.94 | $0.90 | |
| Weighted Average Basic Share | $96.9M | $96.7M | $96.7M | $97M | $97.1M | |
| Weighted Average Diluted Share | $96.9M | $96.9M | $97M | $97.5M | $98M | |
| EBITDA | $211M | $183M | $205M | $216M | $216M | |
| EBIT | $173M | $137M | $158M | $165M | $159M | |
| Revenue (Reported) | $203M | $212M | $235M | $234M | $248M | |
| Operating Income (Reported) | $120M | $106M | $121M | $123M | $122M | |
| Operating Income (Adjusted) | $173M | $137M | $158M | $165M | $159M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $825M | $900M | $921M | $976M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $165M | $168M | $177M | $205M | |
| Gross Profit | -- | $660M | $732M | $744M | $771M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $103M | $105M | $165M | $181M | $173M | |
| Operating Expenses | -- | $255M | $283M | $281M | $275M | |
| Operating Income | -- | $405M | $449M | $463M | $496M | |
| Net Interest Expenses | $76M | $105M | $141M | $147M | $158M | |
| EBT. Incl. Unusual Items | -- | $405M | $473M | $497M | $511M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $104M | $90M | $137M | $96M | |
| Net Income to Company | -- | $301M | $383M | $360M | $415M | |
| Minority Interest in Earnings | -$9M | -$12M | -$11M | -$12M | -$13M | |
| Net Income to Common Excl Extra Items | -- | $289M | $372M | $348M | $402M | |
| Basic EPS (Cont. Ops) | -- | $2.99 | $3.83 | $3.60 | $4.15 | |
| Diluted EPS (Cont. Ops) | -- | $2.99 | $3.81 | $3.58 | $4.11 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | $712M | $790M | $842M | $889M | |
| EBIT | -- | $517M | $603M | $646M | $667M | |
| Revenue (Reported) | -- | $825M | $900M | $921M | $976M | |
| Operating Income (Reported) | -- | $405M | $449M | $463M | $496M | |
| Operating Income (Adjusted) | -- | $517M | $603M | $646M | $667M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $546M | $617M | $677M | $678M | $732M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $111M | $124M | $126M | $133M | $156M | |
| Gross Profit | $435M | $493M | $551M | $545M | $576M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $103M | $76M | $130M | $137M | $128M | |
| Operating Expenses | $119M | $184M | $212M | $198M | $200M | |
| Operating Income | $316M | $309M | $339M | $347M | $376M | |
| Net Interest Expenses | $76M | $77M | $110M | $110M | $119M | |
| EBT. Incl. Unusual Items | $343M | $308M | $359M | $374M | $385M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $91M | $79M | $65M | $102M | $94M | |
| Net Income to Company | $252M | $229M | $294M | $272M | $291M | |
| Minority Interest in Earnings | -$9M | -$9M | -$9M | -$9M | -$10M | |
| Net Income to Common Excl Extra Items | $243M | $220M | $285M | $263M | $281M | |
| Basic EPS (Cont. Ops) | $2.51 | $2.28 | $2.94 | $2.71 | $2.90 | |
| Diluted EPS (Cont. Ops) | $2.51 | $2.28 | $2.93 | $2.71 | $2.87 | |
| Weighted Average Basic Share | $290.6M | $290.3M | $290.1M | $290.7M | $291.2M | |
| Weighted Average Diluted Share | $290.6M | $290.5M | $291.1M | $292.3M | $293.6M | |
| EBITDA | $536M | $526M | $598M | $632M | $671M | |
| EBIT | $425M | $389M | $458M | $485M | $502M | |
| Revenue (Reported) | $546M | $617M | $677M | $678M | $732M | |
| Operating Income (Reported) | $316M | $309M | $339M | $347M | $376M | |
| Operating Income (Adjusted) | $425M | $389M | $458M | $485M | $502M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $46M | $42M | $132M | $61M | $56M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $110M | $126M | $169M | $161M | $154M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $27M | $17M | $25M | $18M | $16M | |
| Total Current Assets | $300M | $483M | $360M | $262M | $272M | |
| Property Plant And Equipment | $3.1B | $3.5B | $3.5B | $3.8B | $4.5B | |
| Long-Term Investments | $1.7B | $1.7B | $1.7B | $2.2B | $1.8B | |
| Goodwill | $471M | $473M | $473M | $473M | $473M | |
| Other Intangibles | $2.2B | $2.1B | $2.1B | $2B | $2B | |
| Other Long-Term Assets | $16M | $21M | $32M | $32M | $31M | |
| Total Assets | $7.8B | $8.3B | $8.2B | $8.8B | $9B | |
| Accounts Payable | $49M | $39M | $22M | $119M | $94M | |
| Accrued Expenses | -- | -- | $4M | $10M | $10M | |
| Current Portion Of Long-Term Debt | $2.9B | $3.2B | $10M | $330M | $165M | |
| Current Portion Of Capital Lease Obligations | $15M | $17M | $16M | $16M | $13M | |
| Other Current Liabilities | $35M | $33M | $26M | $24M | $15M | |
| Total Current Liabilities | $3.4B | $3.3B | $177M | $614M | $434M | |
| Long-Term Debt | -- | -- | $3B | $3.1B | $3.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.1B | $4.1B | $4.1B | $4.7B | $4.7B | |
| Common Stock | -- | -- | $1M | $1M | $1M | |
| Other Common Equity Adj | -$13M | -$11M | -$10M | -$10M | -$8M | |
| Common Equity | $3.6B | $4.1B | $3.9B | $4B | $4.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $155M | $155M | $149M | $147M | $141M | |
| Total Equity | $3.7B | $4.2B | $4B | $4.2B | $4.3B | |
| Total Liabilities and Equity | $7.8B | $8.3B | $8.2B | $8.8B | $9B | |
| Cash and Short Terms | $46M | $42M | $132M | $61M | $56M | |
| Total Debt | $2.9B | $3.2B | $3B | $3.4B | $3.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $128M | $355M | $30M | $77M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $146M | $150M | $146M | $137M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $21M | $21M | $18M | $21M | |
| Total Current Assets | -- | $310M | $533M | $200M | $249M | |
| Property Plant And Equipment | -- | $3.5B | $3.7B | $4.4B | $4.6B | |
| Long-Term Investments | -- | $1.7B | $1.7B | $1.8B | $1.3B | |
| Goodwill | -- | $473M | $473M | $473M | $473M | |
| Other Intangibles | -- | $2.1B | $2B | $2B | $1.9B | |
| Other Long-Term Assets | -- | $32M | $30M | $31M | $39M | |
| Total Assets | -- | $8.1B | $8.4B | $8.9B | $8.6B | |
| Accounts Payable | -- | $30M | $71M | $124M | $67M | |
| Accrued Expenses | -- | $28M | $39M | $39M | $38M | |
| Current Portion Of Long-Term Debt | -- | $10M | -- | $125M | -- | |
| Current Portion Of Capital Lease Obligations | -- | $17M | $17M | $15M | $15M | |
| Other Current Liabilities | -- | $36M | $28M | $24M | $14M | |
| Total Current Liabilities | -- | $195M | $249M | $424M | $262M | |
| Long-Term Debt | -- | $3B | $3.1B | $3.1B | $2.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $4.1B | $4.3B | $4.6B | $4.2B | |
| Common Stock | -- | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | -- | -$10M | -$8M | -$9M | -$7M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $150M | $147M | $142M | $138M | |
| Total Equity | -- | $4B | $4.1B | $4.2B | $4.4B | |
| Total Liabilities and Equity | -- | $8.1B | $8.4B | $8.9B | $8.6B | |
| Cash and Short Terms | -- | $128M | $355M | $30M | $77M | |
| Total Debt | -- | $3B | $3.1B | $3.2B | $2.7B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $220M | $324M | $318M | $382M | $396M | |
| Depreciation & Amoritzation | $110M | $169M | $184M | $189M | $200M | |
| Stock-Based Compensation | -- | $6M | $12M | $17M | $20M | |
| Change in Accounts Receivable | -$20M | -$16M | -$43M | $8M | $7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $390M | $597M | $572M | $725M | $798M | |
| Capital Expenditures | $211M | $518M | $140M | $338M | $772M | |
| Cash Acquisitions | -$2.4B | -$35M | -$11M | -$557M | -$7M | |
| Cash From Investing | -$2.6B | -$714M | $123M | -$854M | -$351M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$559M | -$244M | -$263M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | $253M | $3.1B | $961M | $540M | |
| Long-Term Debt Repaid | -- | -- | -$3.2B | -$636M | -$705M | |
| Repurchase of Common Stock | -- | -- | -- | -$3M | -- | |
| Other Financing Activities | $956M | -$140M | $87M | -$20M | -$24M | |
| Cash From Financing | $2.2B | $113M | -$605M | $58M | -$452M | |
| Beginning Cash (CF) | $26M | $46M | $42M | $132M | $61M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $20M | -$4M | $90M | -$71M | -$5M | |
| Ending Cash (CF) | $46M | $42M | $132M | $61M | $56M | |
| Levered Free Cash Flow | $179M | $79M | $432M | $387M | $26M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $105M | $77M | $116M | $94M | $91M | |
| Depreciation & Amoritzation | $38M | $46M | $47M | $51M | $57M | |
| Stock-Based Compensation | -- | -- | $5M | $5M | $6M | |
| Change in Accounts Receivable | -$30M | -$38M | -$13M | -$2M | $5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $157M | $136M | $195M | $225M | $205M | |
| Capital Expenditures | $94M | $36M | $118M | $201M | $81M | |
| Cash Acquisitions | -$14M | -$7M | -$2M | -- | -$3M | |
| Cash From Investing | -$102M | -$38M | -$119M | -$192M | $346M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$62M | -$67M | -$71M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $286M | $25M | -- | $85M | $40M | |
| Long-Term Debt Repaid | $29M | -$27M | -- | -$60M | -$509M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$386M | -$5M | -$4M | -$6M | -$7M | |
| Cash From Financing | -$71M | -$7M | -$66M | -$48M | -$547M | |
| Beginning Cash (CF) | $71M | $37M | $345M | $45M | $73M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$16M | $91M | $10M | -$15M | $4M | |
| Ending Cash (CF) | $55M | $128M | $355M | $30M | $77M | |
| Levered Free Cash Flow | $63M | $100M | $77M | $24M | $124M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $301M | $383M | $360M | $415M | |
| Depreciation & Amoritzation | -- | $195M | $187M | $196M | $222M | |
| Stock-Based Compensation | -- | -- | $13M | $19M | $22M | |
| Change in Accounts Receivable | -- | -$20M | -$4M | $4M | $8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $607M | $682M | $765M | $795M | |
| Capital Expenditures | $440M | $174M | $217M | $787M | $410M | |
| Cash Acquisitions | -$30M | -$16M | -$4M | -$559M | -$5M | |
| Cash From Investing | -- | $50M | -$190M | -$927M | $75M | |
| Dividends Paid (Ex Special Dividend) | -- | -$501M | -$240M | -$258M | -$276M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $591M | $760M | $345M | |
| Long-Term Debt Repaid | -- | -$3.2B | -$599M | -$635M | -$869M | |
| Repurchase of Common Stock | -- | -- | -$3M | -- | -- | |
| Other Financing Activities | -- | $80M | -$14M | -$30M | -$23M | |
| Cash From Financing | -- | -$584M | -$265M | -$163M | -$823M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $73M | $227M | -$325M | $47M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | $433M | $465M | -$22M | $385M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $252M | $229M | $294M | $272M | $291M | |
| Depreciation & Amoritzation | $111M | $137M | $140M | $147M | $169M | |
| Stock-Based Compensation | -- | -- | $13M | $15M | $17M | |
| Change in Accounts Receivable | -$16M | -$20M | $19M | $15M | $16M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $454M | $464M | $574M | $614M | $611M | |
| Capital Expenditures | $440M | $96M | $173M | $622M | $260M | |
| Cash Acquisitions | -$30M | -$11M | -$4M | -$6M | -$4M | |
| Cash From Investing | -$601M | $163M | -$150M | -$223M | $203M | |
| Dividends Paid (Ex Special Dividend) | -- | -$501M | -$182M | -$196M | -$209M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $286M | $3.1B | $591M | $390M | $195M | |
| Long-Term Debt Repaid | -- | -$3.2B | -$596M | -$595M | -$759M | |
| Repurchase of Common Stock | -- | -- | -$3M | -- | -- | |
| Other Financing Activities | -$130M | $90M | -$11M | -$21M | -$20M | |
| Cash From Financing | $156M | -$541M | -$201M | -$422M | -$793M | |
| Beginning Cash (CF) | $303M | $108M | $758M | $201M | $170M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9M | $86M | $223M | -$31M | $21M | |
| Ending Cash (CF) | $312M | $194M | $981M | $170M | $191M | |
| Levered Free Cash Flow | $14M | $368M | $401M | -$8M | $351M | |
Get DTM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DTM
Sector
P/E ratio
24.55x
10.16x
PEG ratio
1.66x
0.02x
P/B ratio
2.32x
1.04x
Price / LTM sales
10.12x
0.92x
Growth Metrics
DTM
Sector
Revenue growth
5.98%
-3.51%
Earnings growth
-4.26%
-5.45%
Revenue (5-year growth)
13.71%
7.23%
Earnings forecast
$0.96
$0.26
Profitability
DTM
Sector
Profitability FY 2023
$740M
$145.2M
Return on invested capital
5.45%
5.04%
Return on assets
4.53%
3.75%
Return on equity
9.35%
7.95%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
14
Estimated Next Earnings Date
Jan
28
Balance Sheet
DTM
Sector
Total cash
$77M
$15M
Short term investments
--
$5.5M
Total assets
$9B
$442.9M
Long term debt
$2.7B
$122.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
